Abstract
Recent studies indicate that ischemic preconditioning (IP) may be mediated by adenosine (ADO) receptor stimulation. This study compared the effects of adenosine pretreatment on myocardial metabolism and function with those of IP. Control hearts (C) underwent 15 min LAD occlusion (occl) followed by 120 min reperfusion (R). ADO (200/μg/kg/min) was infused into left atrium for 15 min starting at 20 min before LAD occl. IP was elicited by two cycles of 5 min occl & 5 min R. Tissue levels of ATP. creatine phosphate (CP) and pH in the area at risk were measured by 31 P-MRS, and %segment shortening (%SS) by sonomicrometry ADO infusion decreased blood pressure (–26%) and heart rate (–13%), and increased three times regional myocardial blood flow (RMBF). However, within 5 min after stopping ADO infusion, hemodynamic parameters returned to baseline. During sustained ischemia and reperfusion, there were no differences in hemodynamic parameters or RMBF among three groups. 15 min occl 120 min R 120 min R Groups ATP CP pH ATP CP %SS C(n = 10) 64 ± 7% 7 ± 6% 6.3 ± 0.2 71 ± 7% 105 ± 12% 39 ± 16% ADO (n = 10) 76 ± 6% * 9 ± 6% # 6.5 ± 0.1 * 90 ± 8% * 101 ± 6% # 29 ± 6% IP(n = 10) 74 ± 9% * 18 ± 6% * 6.6 ± 0.1 * 91 ± 90% 126 ± 7% 32 ± 16% ATP, CP and %SS values; % of baseline * p < 0.05 vs C # p < 0.05 vs IP ADO pretreatment and IP had similar effects on ATP and pH, but not on CP. In spite of the protective effects on myocardial metabolism during ischemia and reperfusion, neither of the interventions improved %SS after ischemia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.